IROA Metabolomics Workflow for Drift-Resistant Compound Quantitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current metabolomic techniques face challenges in accurately comparing samples run on different instruments or over time due to instrument drift, chromatographic drift, and environmental conditions, leading to reproducibility issues and difficulties in identifying and quantifying compounds with similar masses or formulae.
Innovation Solution
The IROA workflow uses a standardized 'Matrix' sample with symmetrical IROA peaks, created by labeling metabolites with specific isotopic ratios, allowing for triply redundant identification and quantitation through mass spectral analysis, combined with ion mobility and fragmentation techniques to ensure consistent compound identification across platforms and time.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If samples are analyzed on different instruments or over time, then more data can be collected, but measurement precision deteriorates due to instrument drift and chromatographic drift
Solution Approach 1:
The patent introduces an IROA Matrix sample as an intermediary reference material that mediates between different analytical systems and time points. This Matrix contains metabolites labeled with non-natural isotopic ratios (e.g., 95% 13C) that create distinctive IROA peak patterns. By spiking all samples with this standardized Matrix and analyzing them together, the system creates a common reference framework that corrects for instrument drift and chromatographic variability, enabling precise comparisons across different instruments and time periods.
2Quantity of substance
If metabolites with similar masses or formulae are analyzed, then more comprehensive metabolome coverage is achieved, but identification accuracy deteriorates due to mass spectral overlap
Solution Approach 1:
The patent applies local quality by making each metabolite identifiable through its unique local isotopic signature within the mass spectrum. The IROA Matrix introduces metabolites with non-natural isotopic ratios (e.g., 95% 13C labeling) that create distinctive IROA peak patterns at specific mass positions. When endogenous metabolites co-elute with these labeled standards, the unique isotopic distribution patterns serve as local identifiers that distinguish them from other metabolites with similar masses, enabling accurate identification even in crowded spectral regions.
Solution Approach 2:
The patent uses isotopic ratio changes as a form of spectral 'color' change to differentiate metabolites. By labeling Matrix metabolites with extreme isotopic ratios (95% 13C vs. natural abundance), these metabolites produce distinctive IROA peak patterns that appear as unique spectral signatures. This isotopic 'coloring' allows the system to distinguish between metabolites with identical or similar masses by their characteristic isotopic distribution patterns, analogous to how different colors help distinguish objects.
3Measurement precision
If baseline chromatographic separation is required for accurate quantitation, then measurement precision improves, but device complexity and analysis time increase
Solution Approach 1:
The patent replaces the mechanical chromatographic separation system with a spectral identification system based on isotopic ratios. Instead of relying on complete physical separation of metabolites through complex chromatography, the method uses the distinctive IROA peak patterns created by non-natural isotopic labeling to identify and quantify metabolites directly from the mass spectral data. This substitution of spectral identification for mechanical separation simplifies the analytical system while maintaining or improving quantitation accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables accurate and reproducible identification and quantitation of metabolites in complex samples without the need for baseline chromatographic separation, ensuring consistent results across different analytical systems and over time, and providing a mechanism for quality control and error correction.
Implementation Method 1
mass spectral analysis
Implementation Method 2
ion mobility
Data Source
AI summary
An IROA Matrix of metabolite compounds is disclosed. Each of whose compounds has a molecular weight of 2000 AMU or less, and is present as first and second isotopomers that are equally present at two predetermined isotopomeric balances, and contain 2 to 10% of a first isotope, and 90 to 98% of a second isotope, respectively. A reagent pair for transforming a natural abundance mass spectral analysis metabolite sample into an IROA sample is also disclosed and comprises two reactively identical reagents that constitute first and second isotopomers containing 2 to 10% of a first isotope, and 90 to 98% of a second isotope, respectively. Each of the reagent pair contains the same reactive group that reacts with and bonds to a functional group of one or more compounds present in a composition of biologically-produced metabolite compounds. Methods of making and using the above and related materials are also disclosed.